The Impact of VEGF Inhibition on Clinical Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy: A Retrospective Cohort Study

BACKGROUND: In recent years, immune checkpoint inhibitors (ICIs) in combination with chemotherapy have increased survival in patients with advanced non-small cell lung cancer (NSCLC). Vascular endothelial growth factor (VEGF), which plays a key role in tumor angiogenesis, is an immunological modulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanimura, Keiko, Yamada, Tadaaki, Omura, Ayaka, Shiotsu, Shinsuke, Kataoka, Nobutaka, Takeda, Takayuki, Taniguchi, Ryusuke, Yamada, Takahiro, Takeuchi, Mayumi, Chihara, Yusuke, Morimoto, Yoshie, Iwasaku, Masahiro, Kaneko, Yoshiko, Uchino, Junji, Takayama, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194394/
https://www.ncbi.nlm.nih.gov/pubmed/34123822
http://dx.doi.org/10.3389/fonc.2021.663612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194394/
https://www.ncbi.nlm.nih.gov/pubmed/34123822
http://dx.doi.org/10.3389/fonc.2021.663612

Ejemplares similares